Trulieve Cannabis Corp
CNSX:TRUL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Microware Group Ltd
HKEX:1985
|
HK |
|
Tianjin Hi-Tech Development Co Ltd
SSE:600082
|
CN |
|
Rimini Street Inc
F:0QH
|
US |
|
BOC International China Co Ltd
SSE:601696
|
CN |
|
Rightway Holdings Co Ltd
SSE:600321
|
CN |
|
S
|
Sanyo Special Steel Co Ltd
TSE:5481
|
JP |
|
Tasman Resources Ltd
ASX:TAS
|
AU |
|
MotorCycle Holdings Ltd
ASX:MTO
|
AU |
|
Investec PLC
LSE:INVP
|
UK |
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
US |
|
X
|
Xiangtan Electric Manufacturing Co Ltd
SSE:600416
|
CN |
|
Urban Jakarta Propertindo Tbk PT
IDX:URBN
|
ID |
|
Wantedly Inc
TSE:3991
|
JP |
|
Desktop Metal Inc
NYSE:DM
|
US |
|
C
|
CAB Cakaran Corporation Bhd
KLSE:CARLSBG
|
MY |
Trulieve Cannabis Corp
Research & Development
Trulieve Cannabis Corp
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Trulieve Cannabis Corp
CNSX:TRUL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Research & Development
-$14.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Research & Development
-$9.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-5%
|
|
|
Pfizer Inc
NYSE:PFE
|
Research & Development
-$10.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Research & Development
-$15.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Research & Development
-$13.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-11%
|
|
Trulieve Cannabis Corp
Glance View
Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. The company is headquartered in Quincy, Florida and currently employs 9,000 full-time employees. The company went IPO on 2018-09-25. The firm is a multi-state operator in the United States operating in states, with market positions in Arizona, Florida, and Pennsylvania. The company is providing products across its brand portfolio and delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. The company operates in regulated markets that require knowledge in cultivation, manufacturing, retail and logistics. The firm utilizes critical ethanol extraction to obtain the cannabis oil used in its products. The company also utilizes carbon dioxide (CO2) extraction for terpene extraction as well as a line of CO2 vaporizer cartridges. The firm has developed a suite of products with stock keeping units (SKUs), including flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays.
